Comparing oral NSAI to acetaminophen or placebo for treating renal colic after emergency discharge
Official title: The Investigation of the Efficacity and Safety of Oral Non Steroidal Anti Inflammatory (NSAI) Drugs Such as Piroxicam as a Second Line Treatment of Patients Consulting the Emergency Department for Renal Colics
Run by University of Monastir · NCT05722782 · Data updated 2026-11-12
This study is testing whether a pain medication called piroxicam works better than acetaminophen or a placebo for adults who have been treated for kidney stone pain in the emergency room.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | University of Monastir Academic / other |
| Locations | 1 site (Monastir) |
| Status | Recruiting |
| Started | July 1, 2023 |
| Main results expected | June 2027 |
| Study ends | December 2027 |
| Registry record updated | November 14, 2023 |
| Trial ID | NCT05722782 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old who have been treated for renal colic in the emergency department and can consent to participate.
✕Probably not a fit
Patients with contraindications to NSAI or acetaminophen treatment will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of oral non-steroidal anti-inflammatory drugs (NSAI), specifically piroxicam, in treating patients discharged from the emergency department after experiencing renal colic. The research aims to assess the recurrence of pain, reconsultation rates, and hospital admissions among patients receiving piroxicam compared to those receiving acetaminophen or a placebo. By focusing on a common yet under-researched condition, the study seeks to provide clearer recommendations for outpatient treatment of renal colic. The study will include adult patients who have been treated for renal colic in the emergency department and consent to participate.
Why it matters
Potential benefit: If successful, this study could provide a more effective outpatient treatment option for patients suffering from renal colic.
How similar studies have gone: While there is limited research specifically on oral NSAI for renal colic, similar studies have explored NSAI use in pain management, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Over 18 years old * Consenting to participate in the study * Patients treated in the ED for RC * No contraindications of NSAI or paracetamol treatment Exclusion Criteria: * Contraindication of NSAI treatment * Patients non reachable by telephone call * Patients that did not receive or use the treatment
Where it's running
-
Fattouma Bourguiba University Hospital
Monastir, Tunisia Recruiting
Study contacts
- Study coordinator: Nouira semir, MD
- Email: semir.nouira@rns.tn
- Phone: 73106000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AR/VR calming for emergency kidney stone pain
This will see if using a calming AR/VR headset alongside usual pain medicines helps people in the emergency room who have kidney stone pain.
-
Which works better for kidney stone pain in the ED: IV dexamethasone or nebulized terbutaline?
In adults with acute renal colic and pain, researchers are testing whether IV dexamethasone or nebulized terbutaline provides faster or greater relief compared with placebo.
-
Ear pressure points plus pain meds for faster kidney stone pain relief
This study will see if adding ear acupressure to usual NSAID pain medicine helps adults with kidney stone pain feel better faster.
-
Probiotics for infant colic: does daily L. reuteri help crying time?
This study tests whether giving healthy infants with Rome IV–defined colic a daily probiotic (L. reuteri) reduces crying and fussing more quickly than a placebo.
-
BioAmicus Complete for infants with colic, reflux, constipation, or loose stools (0–24 months)
This study will see if the multistrain probiotic BioAmicus Complete can help reduce caregiver‑reported tummy symptoms in infants aged 0–24 months.
-
Probiotics for reducing crying in infants with colic
This study is testing if a probiotic can help reduce crying in babies with colic compared to a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.